Your Health, We Care
In the pursuit of health and recovery, rational use of drugs is a crucial part. Patients should be fully aware of the information about the drug, including but not limited to efficacy, dosage, and contraindications, before using any drug. Be sure to follow the doctor's guidance and do not increase or decrease the dose or change the drug at will, so as not to affect the efficacy or cause adverse reactions; Be aware of drug-drug interactions and avoid self-medication.
Fidaxomicin is a white to off-white film-coated oblong tablet and should be used as directed by a healthcare practitioner.How much do the different versions of Fidaxomicin cost?Pri···【more】
Article source：Captain MedicineRelease date：2024-08-28Recommended：447
Fidaxomicin works by inhibiting the RNA polymerase of bacteria, which has little damage to normal intestinal colonies and is highly safe.How many versions of Fidaxomicin are there?···【more】
Article source：Captain MedicineRelease date：2024-08-28Recommended：471
Fidaxomicin is a macrolide antibiotic developed by Optimer and approved by the FDA in 2011 for the treatment of Clostridium difficile-associated diarrhea (CDAD).What is Fidaxomicin···【more】
Article source：Captain MedicineRelease date：2024-08-28Recommended：552
Balversa is specifically designed for patients with advanced urothelial carcinoma, targeting patients with FGFR mutations and bringing new hope to patients by inhibiting cancer cel···【more】
Article source：Captain MedicineRelease date：2024-08-28Recommended：412
Balversa is a targeted drug targeting FGFR mutations for the treatment of advanced urothelial carcinoma, inhibiting cancer cell growth by inhibiting the FGFR signaling pathway, pro···【more】
Article source：Captain MedicineRelease date：2024-08-28Recommended：534
Balversais an oral anti-tumor drug for the treatment of urothelial carcinoma with FGFR2/3 mutations, which blocks tumor growth by inhibiting FGFR activity, but it is necessary to p···【more】
Article source：Captain MedicineRelease date：2024-08-28Recommended：387
Balversa is a new anti-cancer drug targeting FGFR, targeting urothelial carcinoma with specific gene mutations, accurately blocking tumor growth signals, and bringing new hope to p···【more】
Article source：Captain MedicineRelease date：2024-08-28Recommended：439
Balversais an oral anti-cancer drug mainly used for the treatment of advanced or metastatic urothelial carcinoma with FGFR2/3 mutations, which shows anti-tumor potential by inhibit···【more】
Article source：Captain MedicineRelease date：2024-08-28Recommended：530
Balversais an anti-tumor drug for FGFR mutant tumors, which is usually administered orally in clinical practice and has excellent tumor inhibition ability.What are the precautions ···【more】
Article source：Captain MedicineRelease date：2024-08-27Recommended：449
Balversa is an innovative targeted therapy drug that is clinically used in patients with FGFR mutations such as urothelial carcinoma and has a significant antitumor effect through ···【more】
Article source：Captain MedicineRelease date：2024-08-27Recommended：416
Stipentol is an anti-epileptic drug that reduces seizures primarily by boosting the GABA system in the brain. By stabilizing the excitability of neurons, the frequency of seizures ···【more】
Article source：Captain MedicineRelease date：2024-08-27Recommended：476
Alpelisib is the drug of choice for patients with PIK3CA-mutated breast cancer and offers new treatment hope for patients with advanced and metastatic breast cancer, especially tho···【more】
Article source：Captain MedicineRelease date：2024-08-27Recommended：459
On November 21, 2025, the U.S. Food and Drug Administration (FDA) approved the regimen of pembrolizu···【more】
Recommended：[list:visits]2025-17-12
Lung cancer is the most rapidly increasing malignant tumor with the fastest increasing morbidity and···【more】
Recommended：[list:visits]2024-09-07
Lucius Pharmaceuticals Version of Vibegron Now Available1.Basic Drug InformationVibegron (generic na···【more】
Recommended：[list:visits]2026-06-08
In recent years, leveraging the World Trade Organization (WTO) patent waiver for least-developed cou···【more】
Recommended：[list:visits]2026-05-08
How Can Chinese Patients Access Generic Drugs from Laos?In recent years, generic drugs from Laos hav···【more】
Recommended：[list:visits]2026-04-08
Lucius Pharmaceuticals version of Ibrutinib is now availableIn a randomized controlled trial of 269 ···【more】
Recommended：[list:visits]2026-03-08
Leveraging the WTO patent waiver for least-developed countries (extended to 2033), Laos has seen rap···【more】
Recommended：[list:visits]2026-31-07
Alectinib Has Been Launched in LaosAlectinib is an oral targeted therapeutic drug belonging to the c···【more】
Recommended：[list:visits]2026-30-07
Lucius Pharmaceuticals (Lao) LTD. (Lucius Pharmaceuticals), with its manufacturing campus in Laos located in the capital city of Vientiane in 2020, officially begins its great journey to make effective and affordable medicines available to people in need around the world...More
Lucius Pharmaceutical Co., Ltd., was established in 2020 in Vientiane, the capital of Laos. It aims to offer safe, effective, and affordable medicines globally. With a factory spanning 25,000 square meters, the company manufactures 200+ generic drugs in diverse therapeutic fields.
Address: No.26 Thongmang village, Xaythany district, Vientiane Capital, Laos
E-mail:laoslucius@gmail.com
Name: Lucius
Telegram name: Vira
No.:0085253923643
Telegram name: Vira
No.:0085253923643
